openPR Logo
Press release

Clinical Trials Market Opportunities in Future, Business Growth Analysis by Top Countries Data and Industry Players by 2028

07-25-2023 02:56 PM CET | Health & Medicine

Press release from: The Insight Partners

Clinical Trials Market

Clinical Trials Market

The clinical trials market size market was valued at US$ 55,051.94 million in 2022 and is projected to reach US$ 76,023.44 million by 2028; it is estimated to record a CAGR of 5.5% from 2023 to 2028. Clinical trials are research studies conducted to test a medical, surgical, or behavioral intervention in people. These trials are the primary ways of determining the safety and effectiveness of a new treatment or prevention (such as a new drug, diet, or medical device) in people. Often, a clinical trial is designed to learn if a new treatment is more effective or has less harmful side effects than existing treatments.

Get PDF Sample Copy of this Report -

https://www.theinsightpartners.com/sample/TIPRE00006203/?utm_source=OpenPR&utm_medium=10723

Clinical Trials Market: Regional Analysis-

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2028. These analyses will help the reader to understand the potential worth of investment in a particular region. The report offers in-depth assessment of the growth and other aspects of the Clinical Trials Market in important regions. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

Clinical Trials Market: Competitive Landscape-

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Speak to Our Analyst at -

https://www.theinsightpartners.com/speak-to-analyst/TIPRE00006203/?utm_source=OpenPR&utm_medium=10723

Company Profiles-

- IQVIA Holdings Inc
- Parexel International Corp
- IXICO Plc
- Charles River Laboratories International Inc
- ICON Plc
- WuXi AppTec Co Ltd,
- SGS SA
- Syneos Health Inc
- SIRO Clinpharm Pvt Ltd
- Thermo Fisher Scientific Inc
- Laboratory Corp of America Holdings

Leading market players and manufacturers are studied to help give a brief idea about them in the report. The challenges faced by them and the reasons they are on that position are explained to help make a well informed decision. Competitive landscape of Clinical Trials Market is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.

NOTE: Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 analysis of markets and industries. Cordially get in touch for more details.

Segments-

Based on phase, the clinical trials market is categorized into Phase I, Phase II, Phase III, and Phase IV. The Phase III segment held the largest market share in 2022, and it is estimated to register the highest CAGR during the forecast period. The Phase III is most expensive phase as it involves a vast number of subjects. The stage assists in determining the short-term and long-term efficacy of the active pharmaceutical ingredients. Thus, the assessment is done to know the total and associated therapeutic values of formulated drug. It also assists in complying with FDA standards that help introduce the drug into the market and complete the required licensing applications. In March 2023, AbbVie announced topline results from a Phase 2 study of RINVOQ, 30 mg (upadacitinib) when given alone or in combination therapy with a Bruton's Tyrosine Kinase inhibitor, once daily in patients with moderately to severely active systemic lupus erythematosus (SLE). Based on the results, AbbVie is advancing its clinical program of upadacitinib in SLE patients to Phase 3. Therefore, the successful transition from the Phase II to Phase III studies favors the growth of the clinical trials market for the Phase III segment.

Order a copy of this research study at -

https://www.theinsightpartners.com/buy/TIPRE00006203/?utm_source=OpenPR&utm_medium=10723

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trials Market Opportunities in Future, Business Growth Analysis by Top Countries Data and Industry Players by 2028 here

News-ID: 3145308 • Views:

More Releases from The Insight Partners

Rising Hygiene Standards Propel Medical Scrub Market Growth at a 6.3% CAGR
Rising Hygiene Standards Propel Medical Scrub Market Growth at a 6.3% CAGR
New York, US - October 24, 2025 - The Medical Scrub Market is undergoing a transformative phase, shaped by the increasing focus on healthcare hygiene, professional aesthetics, and sustainable apparel solutions. With hospitals, clinics, and healthcare institutions prioritizing infection control and comfort, medical scrubs have evolved from simple uniforms into advanced garments that blend technology, protection, and style. According to recent insights, the market is projected to grow at a CAGR
Beauty Devices Market: Demand Analysis, Key Players, Trends, Sales, Supply, Deployment Model Revenue Data & Forecast to 2031
Beauty Devices Market: Demand Analysis, Key Players, Trends, Sales, Supply, Depl …
Global Beauty Devices Market Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00008260?utm_source=OpenPR&utm_medium=10881 Key Players Analysis: NuFACE The Procter & Gamble Co. Koninklijke Philips NV Panasonic Holdings Corp. Tria Beauty Foreo Ya-Man LTD ZIIP Silk?n, MTG Co., Ltd The report covers key developments in the Beauty Devices Market as organic and inorganic growth strategies. Various companies are focusing
Practice Management Systems Market by Medical Composition, Type, End-Use Industry and Region Analysed with Trends and Forecasts to 2031
Practice Management Systems Market by Medical Composition, Type, End-Use Industr …
Global Practice Management Systems Market Report is a professional and in-depth survey on the current state of the Cervical Pillows Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Practice Management Systems Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPHC00002219?utm_source=OpenPR&utm_medium=10881 Key Players Analysis: GE HealthCare Technologies Inc Athenahealth
Wireless Sensors Precision Agriculture Environmental Market to Expand at 8.3% CAGR by 2031
Wireless Sensors Precision Agriculture Environmental Market to Expand at 8.3% CA …
The Insight Partners is proud to announce its newest market report, "Wireless Sensors Precision Agriculture Environmental Market: An In-depth Analysis of the Wireless Sensors Precision Agriculture Environmental Market." The report provides a holistic view of the Wireless Sensors Precision Agriculture Environmental Market and describes the current scenario as well as the growth estimates of the market during the forecast period. Check valuable insights in the Wireless Sensors Precision Agriculture Environmental Market

All 5 Releases


More Releases for Phase

Three-Phase Hybrid Inverter Market Efficient and Reliable Power Conversion Solut …
Global Three-Phase Hybrid Inverter Market Overview: The Three-Phase Hybrid Inverter market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Three-Phase Hybrid Inverter market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth
Clinical Trials by Phase (Phase I, Phase II, Phase III, Phase IV) Market Forecas …
A clinical trial is a research study, where a group of people is given a test or treatment. Clinical trials study the safety and efficacy of tests and treatments. If the test or treatment is safe and meets regulatory requirements, then it is approved as a standard of care. Download Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00006203/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  IQVIA  Parexel International Corporation  Charles River Laboratories  ICON plc  SGS SA  Chiltern International Ltd  Syneos Health  PRA Health Sciences  Wuxi AppTec Inc  Pharmaceutical Product Development,
Digital Phase Shifters Market
Digital Phase Shifters Market A recently identified vacuum in the literature about the creation of digital phase shifters for modern communication systems is attempted to be filled in the book Design of Digital Phase Shifters for Multipurpose Communication Systems. By significantly reducing RF power consumption and improving noise immunity, directed beams enhance the development of new-generation mobile communication systems. In this regard, digital phase shifters in particular, which are part
COVID-19 - Pipeline Analysis 2020 for Global Market | Emphasis on Products cover …
COVID-19 (also known as Anderson COVID-19)?is a viral disease caused by RNA virus, SARS-CoV-2 or commonly known as corona virus. These viruses can cause respiratory, enteric, hepatic, and neurologic diseases. At the end of 2019, a new coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China. It rapidly spread, resulting in an epidemic throughout China, followed by an increasing number of cases in other
Power Metering Market Information by type (smart, digital, analog), by phase (si …
Power Metering Market Information by type (smart, digital, analog), by phase (single phase, three phase) by application (residential, commercial and industrial) and Region - Forecast to 2022 The report for Global Power Metering Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and
HIV Vaccines Market Perceive Aggrandized Growth at a CAGR of 11.48% Till 2023 | …
HIV Vaccines Market Report Added on MarketResearchFuture.com with Overall Analysis. Key developments and Strategies Cover in this Report. The Market for Expected to Grow Globally Over the CAGR of 5 % During the Period 2018 to 2027 from USD 2,702.3 Billion in 2027. HIV Vaccines Market - Segmentation The global HIV vaccines market has been segmented on the basis of basis of antibiotics, type, and lastly, region. Antibiotics have been segmented into dicloxacillin,